Ceftaroline for meticillin-resistant Staphylococcus aureus bacteraemia: Case series and review of the literature.
Int J Antimicrob Agents. 2013 Aug 11;
Authors: Polenakovik HM, Pleiman CM
Abstract
Data regarding ceftaroline use for meticillin-resistant Staphylococcus aureus bacteraemia (MRSAB) are lacking. Here we review the outcomes of 31 patients with MRSAB treated with ceftaroline, including 9 patients with endocarditis. Clinical success was observed in 23 patients (74.2%). Adverse events associated with prolonged therapy were rare and included eosinophilic pneumonia, rash and diarrhoea. We conclude that ceftaroline can be used for MRSAB.
PMID: 23993067 [PubMed - as supplied by publisher]